Decline In French Drug Sales, Health Spend

4 November 1996

Growth in medicine sales in French pharmacies fell during the summer. During January-August they rose 3% compared with 5% in first-half 1996; the only weaker growth rate registered worldwide was in Japan, at 2%.

Meantime, French health fund spending declined 0.4% in September after stabilizing in August, reports the leading fund, the CNAM. Spending on drug prescriptions alone dipped 0.4% compared with a rise in August of 0.4%, and medical fees were down 0.5% in September.

The CNAM says the trend over the last four months considerably reduces the risk of overshooting the government's spending growth limit of 2.1% in general medical practice. Public-sector hospital spending dipped 0.3% in September, and that of the clinics fell 1.2%.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight